Conversely, the same IL-23 polymorphism was linked with statistical significance to an increased susceptibility to paradoxical psoriasiform reactions during anti-TNF therapy in patients with psoriasis or other autoimmune conditions [39]. This evidence concerns the gene TNF and Autoimmunity.